对相关基因的综合性分析揭示了表达-表现型相关性
Wanhao Chi1, Evangelos Kiskinis1,2,3
1The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
bioRxiv : the preprint server for biology
|June 19, 2023
概括
的基因表达因表型而异. 发育性和性脑病变基因 (DEEG) 集中在中枢神经系统,而与有关的基因 (SRG) 则在其他地方发现,为的多样性提供了洞察力.
科学领域:
- 神经遗传学 神经遗传学
- 发育神经科学的发展神经科学.
- 系统生物学 系统生物学
背景情况:
- 是一种常见的神经疾病,具有多种遗传和临床表现.
- 导致的广泛表型变异的潜在因素尚未完全理解.
- 了解基因表达模式对于阐明病的发病过程至关重要.
研究的目的:
- 系统地分析247个相关基因的表达模式.
- 通过人类组织,发育阶段和中枢神经系统细胞亚型,将基因表达与现象相关联.
- 研究核心基因 (CEG),发育性和性脑病变基因 (DEEG) 和相关基因 (SRG) 的时空分布.
主要方法:
- 利用公开可用的数据集来检查基因表达.
- 根据策划的表型将247个基因分类为CEG,DEEG和SRG.
- 在人类组织,发育阶段和中枢神经系统细胞亚型中分析了基因表达.
主要成果:
- DEEG基因在中枢神经系统中表达高,而SRG基因主要存在于非中枢神经系统组织中.
- DEEG和CEG基因在大脑区域表现出动态表达,特别是在产前到婴儿过渡期间.
- 与CEG和SRG基因相比,DEEG基因在GABAergic神经元和非神经元细胞中明显更为丰富.
结论:
- 的基因表达模式与特定的表型相关,区分中枢神经系统中心和全身基因参与.
- 早期发育期间基因的动态时空表达突出了神经发育影响的关键时期.
- 在特定的神经元和非神经元细胞类型中DEEG基因的差异表达表明细胞类型在中具有特定作用.
相关概念视频
01:09Epistasis Analysis
5.1K
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...
5.1K
01:24Epilepsy and Seizures: Overview
230
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
472
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
472
01:13Seizures: Classification
443
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
443
01:33Pleiotropy
40.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.7K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
351
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351